It has been reported that the PI3K/AKT pathway is activated in animal models of cancer pain, neuropathic pain, and migraine, primarily manifested by significant upregulation of AKT, PI3K, and their phosphorylated forms (p‐AKT and p‐PI3K). This evidence concerns the gene AKT1 and migraine disorder.